Bioengineering Synthetic Elastin Conduits For Arterial Revascularisation
Funder
National Health and Medical Research Council
Funding Amount
$624,776.00
Summary
An arterial substitute with both physical and biological properties that mimic those of the human vasculature has long been the holy grail of vascular tissue engineering. We propose synthetic elastin can form the basis of a durable, clinically effective small diameter vascular graft and fill a significant unmet need for a biocompatible vascular substitute.
Biocompatible Synthetic Conduits To Treat Vascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$421,818.00
Summary
Clinically available synthetic conduits used in vascular repair and bypass are fundamentally incompatible with the vasculature. They cause inflammation at the site of implantation and increase the risk of blood clots forming. We have developed a unique method of binding bioactive protein layers to the surface of all polymeric materials and have shown a significant improvement in their compatibility. Grafts coated using our technology stand to dramatically improve the treatment of vascular diseas ....Clinically available synthetic conduits used in vascular repair and bypass are fundamentally incompatible with the vasculature. They cause inflammation at the site of implantation and increase the risk of blood clots forming. We have developed a unique method of binding bioactive protein layers to the surface of all polymeric materials and have shown a significant improvement in their compatibility. Grafts coated using our technology stand to dramatically improve the treatment of vascular disease.Read moreRead less
Bioactive And Biodegradable Scaffold And Novel Graft Source For The Repair Of Large Segmental Bone Defects
Funder
National Health and Medical Research Council
Funding Amount
$451,103.00
Summary
The treatment of large bone defects arising from trauma and tumour remains a challenge to orthopaedic surgeons. This project combines a well-established scaffold that can be custom-made to address patient specific requirements with a novel source of graft that can be harvested in significant volumes with minimal pain and morbidity. This novel tissue engineering approach will be evaluated in a previously established pre-clinical model that reflects the severity of challenging clinical scenarios.
Novel Biocompatible Nickel-free Shape Memory Alloy Scaffolds For Biomedical Applications
Funder
National Health and Medical Research Council
Funding Amount
$530,789.00
Summary
The current project is aimed at the development of a new class of novel biocompatible nickel-free shape memory alloy (SMA) scaffolds for metallic implant applications. The new scaffolds possess the ability to exert a mechanical force on the surrounding bones, and stimulate new bone tissue ingrowth, due to their shape memory effect, superelasticity and bone-mimicking porous structure. The outcomes from this project will provide innovative implant materials.
Pre-clinical Validation Of A Novel Implant For Bone Tissue Engineering
Funder
National Health and Medical Research Council
Funding Amount
$435,767.00
Summary
The aim of this grant to was examine a new method for manufacturing implants to improve repair of critical bone defects. It involves new technology for the manufacture of porous scaffolds and testing their delivery in a biological, bone repair setting.
Bioengineering Endovascular Prostheses With Proactive Biocompatibility
Funder
National Health and Medical Research Council
Funding Amount
$627,950.00
Summary
Metallic cardiovascular implants, such as stents, used in the treatment of heart disease are not compatible with blood. They cause inflammation at the site of implantation and increase the risk of blood clots forming. We have developed a unique method of binding bioactive protein layers to the surface of metal alloys, and shown a significant improvement in their compatibility. Stents coated using our technology stand to dramatically improve the treatment of cardiovascular disease.
Development Of Endovascular Stents With Proactive Biocompatibility
Funder
National Health and Medical Research Council
Funding Amount
$428,470.00
Summary
Metallic cardiovascular implants, such as stents, used in the treatment of heart disease are not compatible with blood. They cause inflammation at the site of implantation and increase the risk of blood clots forming. We have developed a unique method of binding bioactive protein layers to the surface of metal alloys, and shown a significant improvement in their compatibility. Stents coated using our technology stand to dramatically improve the treatment of cardiovascular disease.
Tissue distraction: A novel approach to enhance tissue growth for soft tissue engineering purposes. This project will provide new tissues for the expanding field of regenerative medicine to treat numerous tissue defects and
1.Benefit the health & economic well being of Australian society by rapidly supplying organs and tissues.
2.Benefit the academic community by a multidisciplinary approach, involving several academic Institutions in the fields of surgery, tissue engineering, physiology, morph ....Tissue distraction: A novel approach to enhance tissue growth for soft tissue engineering purposes. This project will provide new tissues for the expanding field of regenerative medicine to treat numerous tissue defects and
1.Benefit the health & economic well being of Australian society by rapidly supplying organs and tissues.
2.Benefit the academic community by a multidisciplinary approach, involving several academic Institutions in the fields of surgery, tissue engineering, physiology, morphology, polymer chemistry & biomolecular engineering that will produce basic scientific data with a practical application. Post-graduate students and staff will train & gain significant knowledge in this area.
3. Benefit industry through new product development and IP. This project advances a platform technology with multiple applications.Read moreRead less